Functional studies on the activity of efflux transporters in an ex vivo model with chicken splenocytes and evaluation of selected fluoroquinolones in this model

Biochemical Pharmacology

Volumn 73, Issue 6, 2007, Pages 752-759

  Haritova, Aneliya Milanova ^b   Schrickx, Jan A ^a   Fink Gremmels, Johanna ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b TRAKIA UNIVERSITY   (Bulgaria)

Author keywords

ABC efflux transporters; Chicken lymphocytes; Fluoroquinolones; Rhodamine 123

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CIPROFLOXACIN; DANOFLOXACIN; DRUG CARRIER; ELACRIDAR; ENROFLOXACIN; FLUORESCENT DYE; GLYCOPROTEIN P; KO 143; MARBOFLOXACIN; MULTIDRUG RESISTANCE PROTEIN; PROTEIN INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; RHODAMINE 123; UNCLASSIFIED DRUG; VALSPODAR; VERLUKAST;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CELL SIZE; CHICKEN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG SCREENING; DRUG TRANSPORT; EX VIVO STUDY; FEMALE; FLUORESCENCE; IN VITRO STUDY; MEMBRANE TRANSPORT; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; SPLEEN CELL; THROMBOCYTE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CHICKENS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOROQUINOLONES; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; RHODAMINE 123; RNA, MESSENGER; SPLEEN; T-LYMPHOCYTES;

EID: 33846877217     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.11.015     Document Type: Article

References (55)

1. Albermann N., Schmitz-Winnenthal H., Zgraggen K., Volk C., Hoffmann M.M., Haefeli W.E., et al. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver. Biochem Pharmacol 70 (2005) 949-958
2. Ayrton A., and Morgan P. Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica 31 (2001) 469-497
3. Balayssaca D., Authiera N., Cayreb A., and Coudorea F. Does inhibition of P-glycoprotein lead to drug-drug interactions?. Toxicol Lett 156 (2005) 319-329
4. Barnes D.M. Expression of P-glycoprotein in the chicken. Comp Biochem Physiol A 130 (2001) 301-310
5. Beck J., Gekelert V., Ringgei M., Handgretinger R., and Niethammer D. Rhodamine 123-efflux from hematopoietic subpopulations and leukaemic blast populations marked by PerCP-conjugated monoclonal antibodies. Cancer Lett 99 (1996) 97-207
6. Bertram E.M., Jilbert A.R., and Kotlarski I. Characterisation of duck thrombocytes. Res Vet Sci 64 (1998) 267-270
7. Choo E.F., Kurnik D., Muszkat M., Ohkubo T., Shay S.D., Higginbotham J.N., et al. Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier. J Pharmacol Exp Ther 317 (2006) 1012-1018 10.1124/jpet.105.099648
8. Collett A., Tanianis-Hughes J., and Warhurst G. Rapid induction of P-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drug interactions?. Biochem Pharmacol 68 (2004) 783-790
9. Cormet-Boyaka E., Huneau J.-F., Morderelle A., Boyaka P.N., Carbon C., Rubinstein E., et al. Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors. Antimicrob Agents Chemother 42 (1998) 2607-2611
10. Daoud R., Kast C., Gros P., and Georges E. Rhodamine 123 binds to multiple sites in the multidrug resistance protein (MRP1). Biochemistry 39 (2000) 15344-15352
11. de Bruin M., Miyake K., Litman T., Robey R., and Bates S.E. Reversal of resistance by GF120918 in cell lines expressing the ABC halftransporter, MXR. Cancer Lett 46 (1999) 117-126
12. Deeley R.G., Westlake C., and Cole S.P.C. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev 86 (2006) 849-899
13. Doyle L.A., Yang W., Abruzzo L.V., Krogmann T., Gao Y., Rishi A.K., et al. A multidrug resistance transporter from MCF-7 breast cancer cells. Proc Natl Acad Sci U.S.A. 95 (1998) 15665-15670
14. Drach D., Zhao S., Drach J., Mahadevia R., Gattringer C., Huber H., et al. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood 80 (1992) 2729-2734
15. Edelmann H.M., Duchek P., Rosenthal F.E., Foger N., Glackin C., Kane S.E., et al. Cmdr1, a chicken P-glycoprotein, confers multidrug resistance and interacts with estradiols. Biol Chem 380 (1999) 231-241
16. Egashira M., Kawamata N., Sugimoto K., Kaneko T., and Oshimi K. P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833. Blood 93 (1999) 599-606
17. Eisenbraun M.D., Mosley R.L., Teitelbaum D.H., and Millera R.A. Altered development of intestinal intraepithelial lymphocytes in P-glycoprotein-deficient mice. Dev Comp Immunol 24 (2000) 783-795
18. Haritova A, Schrickx J, Fink-Gremmels J. MDR1 and MRP2 mRNA expression in poultry tissues, submitted for publication.
19. Hesselink D.A., van Hest R.M., Mathot R.A.A., Bonthuis F., Weimar W., de Bruin R.W.F., et al. Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2. Am J Transplant 5 (2005) 987-994
20. Huet S., Marie J.-P., Gualde N., and Robert J. Reference method for detection of Pgp mediated multidrug resistance in human hematological malignancies: a method validated by the laboratories of the French drug resistance network. Cytometry 34 (1998) 248-256
21. Iida A., Tomita M., and Hayashi M. Regional difference in P-glycoprotein function in rat intestine. Drug Metab Pharmacokinet 20 (2005) 100-106
22. Ito T., Yano I., Tanaka K., and Inui K.-I. Transport of quinolone antibacterial drugs by human P-glycoprotein expressed in a kidney epithelial cell line, LLC-PK1. J Pharmacol Exp Ther 282 (1997) 955-960
23. Kim Y., Brown T.P., and Pantin-Jackwood M.J. Effects of cyclosporin A treatment on the pathogenesis of avian leukosis virus subgroup J infection in broiler chickens with Marek's disease virus exposure. J Vet Sci 4 (2003) 245-255
24. Lacoste-Eleaume A.-S., Bleux C., Quere P., Coudert F., Corbel C., and Kanellopoulos-Langevin C. Biochemical and functional characterization of an avian homolog of the integrin GPIIb-IIIa present on chicken thrombocytes. Exp Cell Res 213 (1994) 198-209
25. Laffont C. Factors affecting the disposition of ivermectin in the target species. Ph.D. thesis, Utrecht University, Utrecht, The Netherlands; 2002.
26. Leslie E.M., Deeley R.G., and Cole S.P.C. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol Membr Transporters Toxicol 204 (2005) 216-237
27. Lin J.H. Drug-drug interaction mediated by inhibition and induction of P-glycoprotein. Adv Drug Deliv Rev 55 (2003) 53-81
28. Loor F., Tiberghien F., Wenandy T., Didier A., and Traber R. Cyclosporins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter. J Med Chem 45 (2002) 4598-4612
29. Lowes S., and Simmons N.L. Multiple pathways for fluoroquinolone secretion by human intestinal epithelial (Caco-2) cells. Br J Pharmacol 135 (2002) 1263-1275
30. Luhtala M. Chicken CD4, CD8ab, and CD8aa T Cell co-Receptor molecules. Poult Sci 77 (1998) 1858-1873
31. Luhtala M., Tregaskes C.A., Young J.R., and Vainio O. Polymorphism of chicken CD8-alpha, but not CD8-beta. Immunogenetics 46 (1997) 396-401
32. Mayer U., Wagenaar E., Dorobek B., Beijnen J.H., Borst P., and Schinkel A.H. Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833. J Clin Invest 100 (1997) 2430-2436
33. Naruhashi K., Tamai I., Li Q., Sai Y., and Tsuji A. Experimental demonstration of the unstirred water layer effect on drug transport in Caco-2 cells. J Pharm Sci 92 (2003) 1502-1508
34. Parasrampuria D.A., Lantz M.V., and Benet L.Z. A human lymphocyte based ex vivo assay to study the effect of drugs on P-glycoprotein (P-gp) function. Pharm Res 18 (2001) 39-44
35. Qadir M., O'Loughlin K.L., Fricke S.M., Williamson N.A., Greco W.R., Minderman H., et al. Cyclosporin A is a broad-spectrum multidrug resistance modulator. Clin Cancer Res 11 (2005) 2320-2326
36. Özvegy-Laczka C., Kfblfs G., Sarkadi B., and Váradi A. Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition. Biochim Biophys Acta 1668 (2005) 53-63
37. Ries S., Kfiufer U., Reinacher M., and Weiss E. Immunomorphologic characterization of chicken thrombocytes. Cell Tissue Res 236 (1984) 1-3
38. Sasabe H., Terasaki T., Tsuji A., and Sugiyama Y. Carrier-mediated hepatic uptake of quinolone antibiotics in the rat. J Pharmacol Exp Ther 282 (1997) 162-171
39. Sasabe H., Kato Y., Suzuki T., Itose M., Miyamoto G., and Sugiyama Y. Differential involvement of multidrug resistance-associated protein 1 and P-glycoprotein in tissue distribution and excretion of grepafloxacin in mice. J Pharmacol Exp Ther 310 (2004) 648-655
40. Schinkel A.H., and Jonker J.W. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 55 (2003) 3-29
41. Schrickx JA, Fink-Gremmels J. Danofloxacin-mesylate is a substrate for ATP-dependent efflux transporters. Br J Pharmacol, in press.
42. Sikri V., Pal D., Jain R., Kalyani D., and Mitra A.K. Cotransport of macrolide and fluoroquinolones, a beneficial interaction reversing P-glycoprotein efflux. Am J Ther 11 (2004) 433-442
43. Steinbach D., Sell W., Voigt A., Hermann J., Zint F., and Sauerbrey A. BCRP gene expression is associated with a poor response to remission induction in therapy in childhood acute myeloid leukemia. Leukemia 16 (2002) 1443-1447
44. Steiner H., Polliack A., Kimchi-Sarfaty C., Libster D., Fibach E., and Rund D. Differences in rhodamine-123 efflux in B-type chronic lymphocytic leukemia suggest possible gender and stage variations in drug-resistance gene activity. Ann Hematol 76 (1998) 189-194
45. Taniguchi K., Wada M., Kohno K., Nakamura T., Kawabe T., Kawakami M., et al. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin resistant human cancer cell lines with decreased drug accumulation. Cancer Res 56 (1996) 4124-4129
46. Tarasova N.I., Seth R., Tarasov S.G., Kosakowska-Cholody T., Hrycyna C.A., Gottesman M.M., et al. Transmembrane inhibitors of P-glycoprotein, an ABC transporter. J Med Chem 48 (2005) 3768-3775
47. Tsujimura S., Saito K., Nakayamada S., Nakano K., and Tanaka Y. Clinical relevance of the expression of P-glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus. Arthritis Rheum 52 (2005) 1676-1683
48. Van Bambeke F., Michot J.-M., and Tulkens P.M. Antibiotic efflux pumps in eukaryotic cells: occurrence and impact on antibiotic cellular pharmacokinetics, pharmacodynamics and toxicodynamics. J Antimicrob Chemother 51 (2003) 1067-1077
49. 1A receptor agonist flesinoxan via P-glycoprotein at the blood-brain barrier. Eur J Pharm Sci 14 (2001) 81-86
50. Wang R.B., Kuo C.L., Lien L.L., and Lien E.J. Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors. J Clin Pharm Ther 28 (2003) 203-228
51. Warrington J.S., Greenblatt D.J., and von Moltke L.L. The effect of age on P-glycoprotein expression and function in the Fischer-344 rat. J Pharmacol Exp Ther 309 (2004) 730-736
52. Webb M., Raphael C., Asbahr H., Erber W., and Meyer B. The detection of rhodamine 123 drug efflux at low levels of drug resistance. Br J Haematol 93 (1996) 650-655
53. Witkowski J.M., and Miller R.A. Increased function of P-glycoprotein in T lymphocyte subsets of aging mice. J Immunol 150 (1993) 1296-1306
54. Yamaguchi H., Yano I., Saito H., and Inui K. Transport characteristics of grepafloxacin and levofloxacin in the human intestinal cell line Caco-2. Eur J Pharmacol 431 (2001) 297-303
55. Yamaguchi H., Yano I., Hashimoto Y., and Inui K. Secretory mechanisms of grepafloxacin and levofloxacin in the human intestinal cell line Caco-2. J Pharmacol Exp Ther 295 (2000) 360-366